- Steinberg GR, Michell BJ, van Denderen BJ
et al (2006) Tumor necrosis factor alpha-
induced skeletal muscle insulin resistance
involves suppression of AMP-kinase signaling.
Cell Metab 4:465–474 - Xiao B, Sanders MJ, Underwood E et al (2011)
Structure of mammalian AMPK and its regula-
tion by ADP. Nature 472:230–233 - Carling D, Thornton C, Woods A, Sanders MJ
(2012) AMP-activated protein kinase: new reg-
ulation, new roles? Biochem J 445:11–27 - Hardie DG (2014) AMPK–sensing energy
while talking to other signaling pathways. Cell
Metab 20:939–952 - Hardie DG (2014) AMP-activated protein
kinase: maintaining energy homeostasis at the
cellular and whole-body levels. Annu Rev Nutr
34:31–55 - Hardie DG, Ashford ML (2014) AMPK: reg-
ulating energy balance at the cellular and whole
body levels. Physiology (Bethesda) 29:99–107 - Hardie DG (2014) A new protein kinase cas-
cade. Nat Rev Mol Cell Biol 15:223 - Ross FA, Jensen TE, Hardie DG (2016) Dif-
ferential regulation by AMP and ADP of
AMPK complexes containing different gamma
subunit isoforms. Biochem J 473:189–199 - Minokoshi Y, Alquier T, Furukawa N et al
(2004) AMP-kinase regulates food intake by
responding to hormonal and nutrient signals
in the hypothalamus. Nature 428:569–574 - Lo ́pez M, Lage R, Saha AK et al (2008) Hypo-
thalamic fatty acid metabolism mediates the
orexigenic action of ghrelin. Cell Metab
7:389–399 - Andrews ZB, Liu ZW, Walllingford N et al
(2008) UCP2 mediates ghrelin’s action on
NPY/AgRP neurons by lowering free radicals.
Nature 454:846–851 - Lage R, Va ́zquez MJ, Varela L et al (2010)
Ghrelin effects on neuropeptides in the rat
hypothalamus depend on fatty acid metabolism
actions on BSX but not on gender. FASEB J
24:2670–2679 - Al MO, Lo ́pez M, Tschop M, Dieguez C,
Nogueiras R (2017) Current understanding
of the hypothalamic ghrelin pathways inducing
appetite and adiposity. Trends Neurosci
40:167–180 - Cui H, Lo ́pez M, Rahmouni K (2017) The
cellular and molecular bases of leptin and ghre-
lin resistance in obesity. Nat Rev Endocrinol
13:338–351 - Ramı ́rez S, Martı ́ns L, Jacas J et al (2013)
Hypothalamic ceramide levels regulated by
CPT1C mediate the orexigenic effect of ghre-
lin. Diabetes 62:2329–2337
36. Lo ́pez M, Varela L, Va ́zquez MJ et al (2010)
Hypothalamic AMPK and fatty acid metabo-
lism mediate thyroid regulation of energy bal-
ance. Nat Med 16:1001–1008
37. Alvarez-Crespo M, Csikasz RI, Martinez-
Sanchez N et al (2016) Essential role of
UCP1 modulating the central effects of thyroid
hormones on energy balance. Mol Metab
5:271–282
38. Martinez-Sanchez N, Moreno-Navarrete JM,
Contreras C et al (2017) Thyroid hormones
induce browning of white fat. J Endocrinol
232:351–362
39. Martı ́nez-Sa ́nchez N, Seoane-Collazo P, Con-
treras C et al (2017) Hypothalamic AMPK-ER
stress-JNK1 axis mediates the central actions of
thyroid hormones on energy balance. Cell
Metab 26:212–219
40. Martı ́nez de Morentin PB, Go ́nzalez-Garcı ́aI,
Martins L et al (2014) Estradiol regulates
brown adipose tissue thermogenesis via hypo-
thalamic AMPK. Cell Metab 20:41–53
41. Tanida M, Yamamoto N, Shibamoto T, Rah-
mouni K (2013) Involvement of hypothalamic
AMP-activated protein kinase in leptin-
induced sympathetic nerve activation. PLoS
One 8:e56660
42. Beiroa D, Imbernon M, Gallego R et al (2014)
GLP-1 agonism stimulates brown adipose tis-
sue thermogenesis and browning through
hypothalamic AMPK. Diabetes 63:3346–3358
43. Whittle AJ, Carobbio S, Martı ́ns L et al (2012)
Bmp8b increases brown adipose tissue thermo-
genesis through both central and peripheral
actions. Cell 149:871–885
44. Martins L, Seoane-Collazo P, Contreras C et al
(2016) A functional link between AMPK and
orexin mediates the effect of BMP8B on energy
balance. Cell Rep 16:2231–2242
45. Martı ́nez de Morentin PB, Whittle AJ, Ferno J
et al (2012) Nicotine induces negative energy
balance through hypothalamic AMP-activated
protein kinase. Diabetes 61:807–817
46. Foretz M, Guigas B, Bertrand L, Pollak M,
Viollet B (2014) Metformin: from mechanisms
of action to therapies. Cell Metab 20:953–966
47. Foretz M, Viollet B (2015) Therapy: metfor-
min takes a new route to clinical efficacy. Nat
Rev Endocrinol 11:390–392
48. Ikegami M, Ikeda H, Ishikawa Y et al (2013)
Olanzapine induces glucose intolerance
through the activation of AMPK in the mouse
hypothalamus. Eur J Pharmacol 718:376–382
49. Ikegami M, Ikeda H, Ohashi T et al (2013)
Olanzapine increases hepatic glucose produc-
tion through the activation of hypothalamic
adenosine 50 -monophosphate-activated
Methods for Brain AMPK 447